These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. [Electroconvulsive therapy: 80 years of use in psychiatry]. Kaliora SC; Zervas IM; Papadimitriou GN Psychiatriki; 2018; 29(4):291-302. PubMed ID: 30814039 [TBL] [Abstract][Full Text] [Related]
66. A Case Report on Neuroleptic Malignant Syndrome (NMS): How to Approach an Early Diagnosis. Paul T; Karam A; Paul T; Loh H; Ferrer GF Cureus; 2022 Mar; 14(3):e23695. PubMed ID: 35505741 [TBL] [Abstract][Full Text] [Related]
67. A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. Gallelli L; Spagnuolo V; Palleria C; De Sarro G; Ferraro M Curr Drug Saf; 2009 May; 4(2):119-20. PubMed ID: 19442104 [TBL] [Abstract][Full Text] [Related]
68. Neuroleptic malignant syndrome: a review and report of six cases. Kasantikul D; Kanchanatawan B J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072 [TBL] [Abstract][Full Text] [Related]
69. [Pathophysiology and therapy of malignant neuroleptic syndrome]. Weller M; Kornhuber J Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662 [TBL] [Abstract][Full Text] [Related]
71. Drug treatment of the neuroleptic malignant syndrome. Sakkas P; Davis JM; Janicak PG; Wang ZY Psychopharmacol Bull; 1991; 27(3):381-4. PubMed ID: 1685592 [TBL] [Abstract][Full Text] [Related]
72. [Neuroleptic malignant syndrome after treatment with olanzapine]. Emborg C Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753 [TBL] [Abstract][Full Text] [Related]
73. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy. Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649 [TBL] [Abstract][Full Text] [Related]
74. Diagnostic, Treatment, and System Challenges in the Management of Recurrent Neuroleptic Malignant Syndrome on a General Medical Service. Verma K; Jayadeva V; Serrano R; Sivashanker K Case Rep Psychiatry; 2018; 2018():4016087. PubMed ID: 29992074 [TBL] [Abstract][Full Text] [Related]
75. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics. Hatch CD; Lund BC; Perry PJ Pharmacotherapy; 2001 Aug; 21(8):1003-6. PubMed ID: 11718487 [TBL] [Abstract][Full Text] [Related]
76. Neuroleptic malignant syndrome in a 4-year-old girl associated with alimemazine. van Maldegem BT; Smit LM; Touw DJ; Gemke RJ Eur J Pediatr; 2002 May; 161(5):259-61. PubMed ID: 12012220 [TBL] [Abstract][Full Text] [Related]